Identifying possible homozygous familial hypercholesterolemia patients: an Italian experts' opinion

• Published in: Giornale italiano di cardiologia (2006) Vol. 24; no. 1; p. 5
• Main Authors: Bilato, Claudio, Zambon, Alberto, Pisciotta, Livia, Citroni, Nadia, Carubbi, Francesca, Zambon, Sabina, Zenti, Maria Grazia, Vinci, Pierandrea, Biolo, Gianni, Bonomo, Katia, Egalini, Filippo, Passaro, Angelina, Nascimbeni, Fabio, Negri, Emanuele, D'Addato, Sergio, Averna, Maurizio, Arca, Marcello, Oliva, Fabrizio, Colivicchi, Furio, Catapano, Alberico
• Format: Journal Article
• Language: Italian
• Published: Italy 01.01.2023
• Subjects: Adolescent; Anticholesteremic Agents - therapeutic use; Cholesterol, LDL; Homozygous Familial Hypercholesterolemia; Humans; Hyperlipoproteinemia Type II - diagnosis; Hyperlipoproteinemia Type II - genetics; Hyperlipoproteinemia Type II - therapy; Proprotein Convertase 9
• ISSN: 1972-6481
• DOI: 10.1714/3934.39174

Homozygous familial hypercholesterolemia (HoFH) is a rare genetic disease characterized by high plasma levels of low-density lipoprotein cholesterol (LDL-C) and massive risk of premature atheromasia and cardiovascular events. HoFH is caused by mutations in several genes, such as LDLR, APOB, PCSK9 and LDLRAP1. If untreated, the average age of death is 18 years old, but fatalities within the first 5 years of age have been recorded. Therefore, early diagnosis and treatment are crucial, in order to prevent and/or delay the cardiovascular complications of LDL-C exposure. Because HoFH is a rare disorder, it is not frequently encountered in daily clinical practice at the primary/secondary unspecialized cardiological centers. Then the availability of practical indications helping to identify HoFH patients or to arise a suspect of HoFH is particularly strategic to promptly start the appropriate lipid-lowering therapy. For such a purpose, a group of Italian experts suggests three useful algorithms to identify cases requiring accurate and specialized clinical evaluation as potential HoFH patients. These cases with suspected HoFH should be addressed to specialized centres for the optimal management of these patients.